Lg Chem, Ltd

Lg Energy Solution, Ltd.

Korea Institute of Science and Technology

Korea Research Institute of Chemical Technology

Yungjin Pharmaceuticals Co., Ltd.

Sung-Gyu Kim

Yang-Kyu Choi

Tae-Sook Jeong

Myung-Sook Choi

Song-Hae Bok

Jae Yang Kong

Chul-Ho Lee

Surk-Sik Moon

Yong-Kook Kwon

Eun-Sook Lee

Byung-Hwa Hyun

Og-Sung Moon

Sae-Bom Lee

Woo Kyu Park

Byung-Tae Ahn

Yoon Sung Jung

A FPCB connector including a first main body to which a first FPCB is coupled, and a second main body to which a second FPCB is coupled, the second main body being coupled to and electrically connected to the first main body. At least one of the first main body and the second main body is coupled to the first FPCB or the second FPCB without soldering.

FPCB connector, and battery module and battery pack including the same

A connector including a housing mounted on a printed circuit board (PCB) and including a sidewall having an empty space that is open to one side and a fixing portion extending from an outer surface of the sidewall, the fixing portion passing through the PCB, a connection terminal having a part passing through the sidewall of the housing and the other part passing through the PCB and configured to be electrically connected to the PCB, and a connection unit including a terminal receiving portion and a coupling portion extending from an outer surface of the terminal receiving portion toward a position of the fixing portion to be mechanically coupled with a part of the fixing portion extending out of the PCB.

Connector

A PCB direct connector including terminal members configured to have a pair of contact portions elastically contacting an upper surface and a lower surface of the circuit board and be electrically connected to conductive patterns disposed on at least one of the upper surface and the lower surface, and a connector housing configured to accommodate the terminal members therein and allow a connector connection portion formed at one side of an end of the circuit board to be fitted into and released from the connector housing.

PCB direct connector

A PCB direct connector is directly mounted to a circuit board, and the PCB direct connector includes terminal members arranged in two rows to respectively contact upper conductive patterns and lower conductive patterns provided to an upper surface and a lower surface of the circuit board, and a connector housing configured to accommodate the terminal members therein and allow a connector connection portion formed at one side of an end of the circuit board to be fitted into and released from the connector housing.

PCB direct connector having two-row terminal structure

A vertical-type direct printed circuit board (PCB) connector including a connector housing directly mounted to one surface of a PCB substrate in a vertical type, and bending terminal members installed inside the connector housing and having one side extending in a first direction corresponding to a direction perpendicular to the one surface of the PCB substrate to be connected to a signal transmission cable and the other side extending in a second direction corresponding to a length direction of contact pads provided to the one surface of the PCB substrate to be connectable to the contact pads.

Vertical-type direct PCB connector

The present invention relates to new quinoline derivatives of formula (1) or their pharmaceutically acceptable salts with caspase-3 inhibitory activity and their preparation methods, wherein Ris H; halogen; Calkyl; Calkoxy; Calkoxyalkyl; or Ccycloalkyl; Ris formula (a); &#x2014;CN; or formula (b); R is H; Caryl unsubstituted or substituted by halogen, Calkyl, Calkoxy or amino; 5&#x2013;15 membered heterocyclic group unsubstituted or substituted by halogen, Calkyl, Calkoxy or amino; or &#x2014;(CH)&#x2014;CHRR. The present invention relates to a pharmaceutical composition for treating caspase-associated diseases by inhibiting the activity of caspase-3 which comprises the compound of formula (1) or its pharmaceutically acceptable salt.

Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same

A method for increasing the plasma high density lipoprotein(HDL) level in a mammal comprises administering a bioflavonoid of formula(I) or plant extract containing same thereto: ##STR1## wherein, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5.sub.7 R.sup.6, R.sup.7, R.sup.8 and R.sup.9 are each independently hydrogen; a hydroxy group; a C.sub.1-9 alkoxy group optionally substituted with one or more substituents selected from the group consisting of a hydroxy, C.sub.1-5 alkoxy, aryloxy, and phenyl group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen, nitro and amido group; a C.sub.5-9 cycloalkyloxy group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen, nitro and amido group; a C.sub.5-9 cycloalkylcarbonyloxy group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen, nitro and amido group; a C.sub.2-10 or C.sub.16-18 acyloxy group optionally substituted with one or more substituents selected from the group consisting of a hydroxy, C.sub.1-5 alkoxy, aryloxy, and phenyl group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen and nitro group; a rutinosyl group; or a rhaminosyl group; and

Bioflavonoids as plasma high density lipoprotein level increasing agent

Growing community of inventors

Daejeon, South Korea

Sung-Gyu Kim